BRIEF: Haixi Pharma delays IPO trading debut

Fujian Haixi Pharmaceuticals Co. Ltd. (2637.HK) said on Thursday night that the trading debut for its Hong Kong IPO, originally scheduled for Friday, will be postponed. It blamed the delay…

BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.  (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…

BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO

Pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) on Friday launched its Hong Kong IPO, seeking to raise about HK$601 million ($77 million) by selling 41.2 million shares for HK$14.75 apiece. The…